Fundz

Specialised Therapeutics Enhances Partnership with Incyte to Market Ruxolitinib Cream in Australia

Sep 20, 2026

Contract Type

partnership

ThailandBiotechnologyHealth CareMedicalTherapeuticsPharmaceutical

Description

Specialised Therapeutics has announced an expansion of its partnership with Incyte to commercialize ruxolitinib cream in Australia. The agreement includes responsibilities for regulatory submissions, medical affairs, marketing, and distribution by ST, while Incyte will handle development and manufacturing.

Company Information

Company

Specialised Therapeutics

Location

Thailand

About

Specialised Therapeutics (ST) is an independent pharmaceutical company committed to developing and providing innovative therapies for patients with rare diseases. The company focuses on enhancing access to specialized medications and technologies to improve patient outcomes. ST operates with a dedicated team that understands local healthcare landscapes and works closely with health authorities and oncologists. Its recent approval of the NERLYNX breast cancer therapy marks a significant milestone in addressing the needs of breast cancer patients in Thailand.

Predictive Intelligence
Strategic

ML-powered predictions for Specialised Therapeutics's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Specialised Therapeutics signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.